Innate Pharma SA (IPHYF)
2.65
0.00 (0.00%)
USD |
OTCM |
Apr 26, 16:00
Innate Pharma 1 Year Total Returns (Daily): -10.17% for April 26, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| April 26, 2024 | -10.17% |
| April 25, 2024 | -10.17% |
| April 24, 2024 | -2.21% |
| April 23, 2024 | -2.21% |
| April 22, 2024 | -2.21% |
| April 19, 2024 | -2.21% |
| April 18, 2024 | -2.21% |
| April 17, 2024 | -2.21% |
| April 16, 2024 | -2.21% |
| April 15, 2024 | -2.21% |
| April 12, 2024 | -2.21% |
| April 11, 2024 | -2.21% |
| April 10, 2024 | -2.21% |
| April 09, 2024 | -2.21% |
| April 08, 2024 | -2.21% |
| April 05, 2024 | -2.21% |
| April 04, 2024 | -2.21% |
| April 03, 2024 | -2.21% |
| April 02, 2024 | -2.21% |
| April 01, 2024 | -4.80% |
| March 28, 2024 | -4.80% |
| March 27, 2024 | -13.63% |
| March 26, 2024 | -11.62% |
| March 25, 2024 | -11.62% |
| March 22, 2024 | -22.24% |
| Date | Value |
|---|---|
| March 21, 2024 | -22.99% |
| March 20, 2024 | -22.99% |
| March 19, 2024 | -22.99% |
| March 18, 2024 | -21.54% |
| March 15, 2024 | -21.54% |
| March 14, 2024 | -21.54% |
| March 13, 2024 | -21.54% |
| March 12, 2024 | -21.54% |
| March 11, 2024 | -21.54% |
| March 08, 2024 | -19.75% |
| March 07, 2024 | -19.75% |
| March 06, 2024 | -14.29% |
| March 05, 2024 | -3.40% |
| March 04, 2024 | -3.40% |
| March 01, 2024 | -9.84% |
| February 29, 2024 | -3.07% |
| February 28, 2024 | -3.07% |
| February 27, 2024 | -3.07% |
| February 26, 2024 | -3.40% |
| February 23, 2024 | -3.40% |
| February 22, 2024 | -3.40% |
| February 21, 2024 | -17.44% |
| February 20, 2024 | -17.44% |
| February 16, 2024 | -17.44% |
| February 15, 2024 | -17.44% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-70.24%
Minimum
Sep 26 2022
90.68%
Maximum
Sep 17 2021
-11.92%
Average
-13.84%
Median
Feb 08 2022
1 Year Total Returns (Daily) Benchmarks
| DBV Technologies SA | -57.11% |
| Cellectis SA | 31.18% |
| PHAXIAM Therapeutics SA (DELISTED) | -- |
| Genfit SA | -5.68% |